NCT07280013 2026-04-17
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
C4 Therapeutics, Inc.
Phase 1 Recruiting
C4 Therapeutics, Inc.
Amgen
Faculdade de Ciências Médicas de Minas Gerais